• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

Evgen Pharma makes progress on two fronts in the field of cancer

steve | 13 July 2021
Categories: Media Coverage

Post navigation

← Evgen Pharma: Johns Hopkins research further assesses the potential of company’s drug to treat COVID-19
Evgen portfolio update on core field of cancer, ‘the R&D is entirely on plan and on budget’ →
Copyright© 2023
  • Privacy Policy
  • Sitemap
Twitter Twitter linkedin linkedin
Get in touch